Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination

Shiho Katsuie; Kenta Nakamura; Eisaku Ogawa; Fuyuko Arakura; Ryuhei Okuyama

doi:10.7759/cureus.28604

Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination

Cureus. 2022 Aug 30;14(8):e28604. doi: 10.7759/cureus.28604. eCollection 2022 Aug.

Authors

Shiho Katsuie¹, Kenta Nakamura¹, Eisaku Ogawa¹, Fuyuko Arakura², Ryuhei Okuyama¹

Affiliations

¹ Department of Dermatology, Shinshu University School of Medicine, Matsumoto, JPN.
² Division of Dermatology, National Hospital Organization Matsumoto Medical Center, Matsumoto, JPN.

Abstract

Palmoplantar pustulosis (PPP) is a rare chronic pustular condition that affects the palms and soles. Smoking and focal infections and dental metal allergies are risk factors for PPP development. Here we report a case of a 60-year-old woman who experienced a relapse of PPP after receiving the COMIRNATY vaccine against COVID-19. The patient relapsed after being in remission for seven years. This article shows the possible implications of COVID-19 vaccination related to the relapse of previous diseases and stresses the importance of careful observation of post-vaccination occurrences of skin eruptions, especially in patients having a history of PPP.

Keywords: covid-19 vaccination; palmoplantar pustulosis; pustular psoriasis; relapse; remission.

Publication types

Case Reports